Equifax (NYSE:EFX) Given New $266.00 Price Target at Oppenheimer

Equifax (NYSE:EFX) had its price objective reduced by Oppenheimer from $271.00 to $266.00 in a research note released on Monday morning,Benzinga reports. Oppenheimer currently has an outperform rating on the credit services provider’s stock.

EFX has been the subject of a number of other research reports. Morgan Stanley dropped their price objective on shares of Equifax from $290.00 to $280.00 and set an “overweight” rating for the company in a report on Wednesday, December 17th. UBS Group raised their price target on shares of Equifax from $287.00 to $297.00 and gave the company a “buy” rating in a research report on Monday, September 15th. Seaport Res Ptn raised Equifax to a “hold” rating in a research report on Wednesday, October 1st. Wells Fargo & Company reduced their price objective on Equifax from $300.00 to $285.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 15th. Finally, Needham & Company LLC reissued a “buy” rating and set a $295.00 target price on shares of Equifax in a research note on Tuesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Equifax presently has an average rating of “Moderate Buy” and an average price target of $274.40.

Equifax Price Performance

EFX stock opened at $221.67 on Monday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $27.13 billion, a PE ratio of 42.06, a P/E/G ratio of 2.27 and a beta of 1.56. Equifax has a 12-month low of $199.98 and a 12-month high of $281.07. The business’s fifty day moving average price is $213.91 and its 200 day moving average price is $234.54.

Equifax (NYSE:EFX) last announced its earnings results on Tuesday, October 21st. The credit services provider reported $2.04 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.10. The company had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.52 billion. Equifax had a return on equity of 19.28% and a net margin of 11.08%.Equifax’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period last year, the business posted $1.85 EPS. Equifax has set its Q4 2025 guidance at 1.980-2.080 EPS and its FY 2025 guidance at 7.550-7.650 EPS. On average, sell-side analysts anticipate that Equifax will post 7.58 EPS for the current year.

Equifax Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Monday, November 24th were issued a $0.50 dividend. The ex-dividend date was Monday, November 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.9%. Equifax’s dividend payout ratio is presently 37.95%.

Insider Activity at Equifax

In other Equifax news, CEO Mark W. Begor sold 21,386 shares of the stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $231.12, for a total value of $4,942,732.32. Following the transaction, the chief executive officer directly owned 22,045 shares in the company, valued at $5,095,040.40. This represents a 49.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Jamil Farshchi sold 4,925 shares of the firm’s stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $238.94, for a total transaction of $1,176,779.50. Following the sale, the executive vice president directly owned 39,364 shares in the company, valued at approximately $9,405,634.16. The trade was a 11.12% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 54,270 shares of company stock valued at $12,580,837. 1.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Equifax

Institutional investors and hedge funds have recently bought and sold shares of the stock. Brighton Jones LLC grew its holdings in shares of Equifax by 49.2% during the fourth quarter. Brighton Jones LLC now owns 3,638 shares of the credit services provider’s stock worth $927,000 after purchasing an additional 1,200 shares during the last quarter. Great Lakes Advisors LLC purchased a new position in Equifax during the 1st quarter worth approximately $204,000. Empowered Funds LLC grew its stake in Equifax by 14.6% during the 1st quarter. Empowered Funds LLC now owns 2,523 shares of the credit services provider’s stock worth $615,000 after buying an additional 321 shares during the last quarter. Geneos Wealth Management Inc. increased its position in Equifax by 42.3% during the first quarter. Geneos Wealth Management Inc. now owns 343 shares of the credit services provider’s stock worth $84,000 after buying an additional 102 shares during the period. Finally, Inspire Investing LLC lifted its stake in Equifax by 28.0% in the first quarter. Inspire Investing LLC now owns 1,295 shares of the credit services provider’s stock valued at $315,000 after buying an additional 283 shares during the last quarter. 96.20% of the stock is owned by hedge funds and other institutional investors.

Equifax Company Profile

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.